Journal
VACCINES
Volume 7, Issue 2, Pages -Publisher
MDPI
DOI: 10.3390/vaccines7020056
Keywords
African swine fever virus; ASFV; vaccines; subunit vaccines; antigens; immunogens; protective immunity; disease enhancement; antibody dependent enhancement
Categories
Funding
- U.S. Department of Homeland Security [DHS-2010-ST-061-AG0001]
- State of Kansas National Bio and Agro-Defense Facility transition funds
Ask authors/readers for more resources
African swine fever virus (ASFV) is the cause of a highly fatal disease in swine, for which there is no available vaccine. The disease is highly contagious and poses a serious threat to the swine industry worldwide. Since its introduction to the Caucasus region in 2007, a highly virulent, genotype II strain of ASFV has continued to circulate and spread into Eastern Europe and Russia, and most recently into Western Europe, China, and various countries of Southeast Asia. This review summarizes various ASFV vaccine strategies that have been investigated, with focus on antigen-, DNA-, and virus vector-based vaccines. Known ASFV antigens and the determinants of protection against ASFV versus immunopathological enhancement of infection and disease are also discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available